PBLS

PARABILIS MEDICINES INC

• TipRanks·22h ago

  Why Is Parabilis Medicines Stock (PBLS) Up 11% Today?

• Seeking Alpha·1d ago

  Regeneron-backed Parabilis rises ahead of trial data for lead asset

• Benzinga·1d ago

  Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday

• Benzinga·1d ago

  Parabilis Medicines To Present Updated Clinical Data For Zolucatetide In Patients With Desmoid Tumors At ESMO Congress 2026

• NASDAQ·5d ago

  Parabilis Begins Dose-Ranging Study For Zolucatetide In Treating FAP; Data By Q1 '27

• Benzinga·6d ago

  Parabilis Medicines Initiates Dose-Ranging Clinical Cohort Evaluating Zolucatetide In Patients With Familial Adenomatous Polyposis As Part Of Ongoing Phase 1/2 Clinical Trial

• TipRanks·09/21 16:06

  Parabilis Medicines falls -12.5%

• NASDAQ·09/18 08:36

  Biotech Stocks At 52-Week Highs - MNOV +36%, PBLS +10%, ABCL +9%, HAE, NEO

• Benzinga·09/17 15:58

  Vicor, Arm Holdings, Micron Technology And Other Big Stocks Moving Higher On Thursday

• TipRanks·09/17 09:00

  Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Parabilis Medicines, Inc. (PBLS) and Acumen Pharmaceuticals (ABOS)

• TipRanks·08/25 13:15

  Parabilis Medicines appoints Craig Tendler to board of directors

• Dow Jones·08/25 11:01

  *Parabilis Medicines Appoints Craig Tendler to Board of Directors

• Dow Jones·08/25 11:00

  Press Release: Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

• NASDAQ·08/18 11:03

  Biotech Stocks At 52-Week Highs - OABI, IOVA, PBLS, RVMD, BLFS

• TipRanks·08/14 16:30

  Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Celcuity (CELC) and Parabilis Medicines, Inc. (PBLS)